艺术
美容与健康
工艺
文化与历史
娱乐
环境
食品与饮料
绿色未来
逆向工程
科学
体育
技术
可穿戴设备
Synthesising Aspirin — The Reaction That Founded Modern Pharmaceuticals
危险内容
Charlie

创建者

Charlie

23. 五月 2026DE
0
0
0
1
0

Synthesising Aspirin — The Reaction That Founded Modern Pharmaceuticals

For thousands of years, healers knew that chewing willow bark eased pain and reduced fever. The active principle — salicin, a glycoside that the body converts to salicylic acid — was isolated by Johann Buchner in 1828 and synthesised from phenol by Hermann Kolbe in 1859. But salicylic acid has a devastating side effect: it burns the stomach lining, causing nausea, bleeding, and ulcers.

In 1897, Felix Hoffmann at the Bayer company in Elberfeld, Germany, acetylated salicylic acid — replacing the free hydroxyl group with an acetyl group by reacting it with acetic anhydride. The product, acetylsalicylic acid (C₉H₈O₄), retained the painkilling and anti-inflammatory properties but was far gentler on the stomach. Bayer marketed it as 'Aspirin' in 1899, and it became the first mass-produced synthetic drug — launching the modern pharmaceutical industry.

The synthesis is a textbook esterification: salicylic acid (2-hydroxybenzoic acid) reacts with acetic anhydride in the presence of a phosphoric acid catalyst to produce acetylsalicylic acid and acetic acid as a by-product: C₇H₆O₃ + C₄H₆O₃ → C₉H₈O₄ + CH₃COOH. The reaction is fast, clean, and produces beautiful white needle-like crystals — one of the most satisfying syntheses in introductory organic chemistry.

SAFETY WARNING: Acetic anhydride is a corrosive irritant — its vapour causes severe eye and respiratory irritation. Phosphoric acid is corrosive. Work in a fume hood or well-ventilated area. Wear goggles and gloves. The product, aspirin, is a real medicine — but the purity of a lab synthesis is unknown, so NEVER ingest the product.

中级
2–3 hours

危险内容

此蓝图包含危险操作。请登录并在账户设置中启用危险内容,以查看分步说明。

CC0 公共领域

此蓝图以 CC0 协议发布。你可以自由复制、修改、分发和使用此作品,无需征得许可。

通过购买蓝图中的产品支持创客,他们将获得 创客佣金 (由供应商设定),或创建此蓝图的新版本并将其作为连接包含在你自己的蓝图中以分享收入。

讨论

(0)

登录 加入讨论

加载评论中...